Dorothée Obach

418 total citations
12 papers, 238 citations indexed

About

Dorothée Obach is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Dorothée Obach has authored 12 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Dorothée Obach's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (7 papers). Dorothée Obach is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (7 papers). Dorothée Obach collaborates with scholars based in France, Egypt and Austria. Dorothée Obach's co-authors include Yazdan Yazdanpanah, Sylvie Deuffic‐Burban, V. Canva, Stanislas Pol, Daniel Dhumeaux, Arnaud Fontanet, Philippe Mathurin, Françoise Roudot‐Thoraval, Michaël Schwarzinger and Sabine Plancoulaine and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Dorothée Obach

12 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dorothée Obach France	8	172	158	48	26	15	12	238
I. Guarnori Italy	10	281 1.6×	287 1.8×	60 1.3×	21 0.8×	9 0.6×	17	350
Iwona Cielniak Poland	7	138 0.8×	133 0.8×	74 1.5×	49 1.9×	102 6.8×	16	271
Ana Arizcorreta Spain	7	316 1.8×	382 2.4×	108 2.3×	44 1.7×	16 1.1×	12	428
Ruben C. Hoogeveen Netherlands	7	213 1.2×	164 1.0×	52 1.1×	17 0.7×	25 1.7×	8	333
Patrizia Caligiuri Italy	10	177 1.0×	131 0.8×	117 2.4×	34 1.3×	17 1.1×	20	299
Stephen Kegg United Kingdom	4	173 1.0×	53 0.3×	66 1.4×	51 2.0×	5 0.3×	11	236
Kelly Wroblewski United States	5	214 1.2×	204 1.3×	70 1.5×	35 1.3×	15 1.0×	10	283
Vithika Suri United States	9	264 1.5×	263 1.7×	52 1.1×	12 0.5×	26 1.7×	40	350
Ellen G. J. Hulskotte Netherlands	8	218 1.3×	129 0.8×	100 2.1×	54 2.1×	22 1.5×	12	309
Charlotte H. S. B. van den Berg Netherlands	9	256 1.5×	220 1.4×	88 1.8×	34 1.3×	6 0.4×	15	301

Countries citing papers authored by Dorothée Obach

Since Specialization

Citations

This map shows the geographic impact of Dorothée Obach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorothée Obach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorothée Obach more than expected).

Fields of papers citing papers by Dorothée Obach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorothée Obach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorothée Obach. The network helps show where Dorothée Obach may publish in the future.

Co-authorship network of co-authors of Dorothée Obach

This figure shows the co-authorship network connecting the top 25 collaborators of Dorothée Obach. A scholar is included among the top collaborators of Dorothée Obach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorothée Obach. Dorothée Obach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Stagg, Helen R., Ross Harris, Dorothée Obach, et al.. (2016). What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis. Thorax. 71(10). 940–949. 19 indexed citations

Deuffic‐Burban, Sylvie, Dorothée Obach, V. Canva, et al.. (2016). Cost‐effectiveness and budget impact of interferon‐free direct‐acting antiviral‐based regimens for hepatitisCtreatment: theFrench case. Journal of Viral Hepatitis. 23(10). 767–779. 21 indexed citations

Obach, Dorothée, Yazdan Yazdanpanah, Gamal Esmat, et al.. (2015). How to optimize hepatitis C virus treatment impact on life years saved in resource‐constrained countries. Hepatology. 62(1). 31–39. 20 indexed citations

Obach, Dorothée, Sylvie Deuffic‐Burban, Gamal Esmat, et al.. (2014). Effectiveness and Cost-effectiveness of Immediate Versus Delayed Treatment of Hepatitis C Virus–Infected Patients in a Country With Limited Resources: The Case of Egypt. Clinical Infectious Diseases. 58(8). 1064–1071. 32 indexed citations

Deuffic‐Burban, Sylvie, Michaël Schwarzinger, Dorothée Obach, et al.. (2014). Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141). Journal of Hepatology. 61(1). 7–14. 47 indexed citations

Cousien, Anthony, Dorothée Obach, Sylvie Deuffic‐Burban, et al.. (2014). Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt. BMC Medical Research Methodology. 14(1). 39–39. 3 indexed citations

Schwarzinger, Michaël, Dorothée Obach, Julien Poissy, et al.. (2014). Effectiveness and cost of quick diagnostic tests to determine tetanus immunity in patients with a wound in french emergency departments. BMC Infectious Diseases. 14(1). 603–603. 7 indexed citations

Deuffic‐Burban, Sylvie, Michaël Schwarzinger, Dorothée Obach, et al.. (2014). O85 SHOULD WE AWAIT INTERFERON-FREE REGIMENS TO TREAT HCV GENOTYPE 1 TREATMENT-NAIVE PATIENTS? A COST-EFFECTIVENESS ANALYSIS (ANRS 12188). Journal of Hepatology. 60(1). S35–S35. 5 indexed citations

Obach, Dorothée, Sylvie Deuffic‐Burban, Gamal Esmat, et al.. (2013). 885 IMMEDIATE vs. DELAYED TREATMENT IN GENOTYPE 4-HCV INFECTED PATIENTS IN A LIMITED RESOURCES COUNTRY: A COST-EFFECTIVENESS ANALYSIS IN EGYPT (ANRS 12215). Journal of Hepatology. 58. S364–S364. 2 indexed citations

10.

Laouenan, Cédric, Sabine Plancoulaine, Mohamed Mostafa, et al.. (2009). Evidence for a dominant major gene conferring predisposition to hepatitis C virus infection in endemic conditions. Human Genetics. 126(5). 697–705. 3 indexed citations

11.

Plancoulaine, Sabine, Mohamed Mostafa, Naglaa Arafa, et al.. (2008). Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut. 57(9). 1268–1274. 43 indexed citations

12.

Gholami, Alireza, Éléonore Réal, Olivier Delmas, et al.. (2008). Mitochondrial Dysfunction in Lyssavirus-Induced Apoptosis. Journal of Virology. 82(10). 4774–4784. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact